SEARCH
EU visit to vaccine plant under scrutiny over AstraZeneca delays
euronews (in English)
2021-02-10
Views
535
Description
Share / Embed
Download This Video
Report
The site at Seneffe, south of Brussels, manufactures the active ingredient of AstraZeneca's COVID-19 vaccine.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x7z8sre" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
04:22
COVID-19 vaccine: EU threatens to block exports over AstraZeneca delivery delays
01:08
EU reaches vaccine delivery deal with AstraZeneca, ending legal battle over supply delays
02:20
EU seeks huge fine in court over AstraZeneca vaccine delivery delays
02:04
Tension rise as EU, Astrazeneca spar over vaccine delays
03:52
Coronavirus pandemic: EU and Astrazeneca battle in court over vaccine delays
06:10
Sputnik V, AstraZeneca vaccine mix approved amid delays | New Day
02:22
EU's Breton says Pfizer and Sputnik V can help offset AstraZeneca vaccine delays
00:54
Covid-19: Delays expected for AstraZeneca vaccine shipments
02:41
EU closes ranks over Covid surge and vaccine delays
02:22
EU sues AstraZeneca over delayed deliveries of Covid-19 vaccine
04:17
Coronavirus pandemic: Confusion over AstraZeneca-EU talks on vaccine delay
02:40
COVID-19 vaccine: EU Commission and AstraZeneca fail to resolve supply row despite crisis talks